Who Owns InflaRx N.V. Stock?
NASDAQ: IFRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 1:16 PM ET
Ownership breakdown
- Held by institutions
- 70.39%
- Held by insiders
- 2.95%
- Institutional holders
- 70
- Institutions 70.4%
- Insiders 2.9%
- Public and other 26.7%
Who owns InflaRx N.V. stock?
Institutional investors own about 70.4% of InflaRx N.V.'s shares, spread across 70 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.95% of IFRX.
The largest institutional holders are Montanova Capital LLC (0.00%), TCG Crossover Management, LLC (97.39%) and FMR, LLC (54.83%). Together, the top 10 institutions control 355.8% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their IFRX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IFRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Montanova Capital LLC | 22.93M | 0.00% | +189.1% |
| TCG Crossover Management, LLC | 14.50M | 97.39% | +100.0% |
| FMR, LLC | 8.16M | 54.83% | +100.0% |
| Commodore Capital Lp | 7.30M | 49.03% | +100.0% |
| Spruce Street Capital LP | 5.35M | 35.95% | +100.0% |
| 683 Capital Management LLC | 5.07M | 34.02% | +52.8% |
| Farallon Capital Management LLC | 3.33M | 22.33% | +100.0% |
| Stempoint Capital LP | 3.23M | 21.68% | +100.0% |
| Great Point Partners LLC | 3.05M | 20.46% | +100.0% |
| Adar1 Capital Management, LLC | 3.00M | 20.15% | +1795.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IFRX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 3.29M | 22.10% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 3.20M | 21.47% |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 1.68M | 11.27% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 376.11K | 2.53% |
| Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF | 46.54K | 0.31% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 43.67K | 0.29% |
| TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund | 23.13K | 0.16% |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 1.36K | 0.01% |
Frequently asked questions
Who is the largest shareholder of InflaRx N.V.?
Montanova Capital LLC is the largest institutional shareholder of IFRX, owning 0.00% of shares outstanding (22.93M shares) as of its latest 13F filing.
What percentage of InflaRx N.V. is owned by institutions?
Institutions own about 70.4% of IFRX shares and 72.5% of the public float.
How much of InflaRx N.V. do insiders own?
Insiders, such as officers and directors, own about 2.95% of IFRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.